Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 1599-1604, April 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jussila, L.
Right arrow Articles by Alitalo, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jussila, L.
Right arrow Articles by Alitalo, K.

Lymphatic Endothelium and Kaposi's Sarcoma Spindle Cells Detected by Antibodies against the Vascular Endothelial Growth Factor Receptor-31

Lotta Jussila, Reija Valtola, Taina A. Partanen, Petri Salven, Päivi Heikkilä, Marja-Terttu Matikainen, Risto Renkonen, Arja Kaipainen, Michael Detmar, Erwin Tschachler, Riitta Alitalo and Kari Alitalo2

Molecular/Cancer Biology Laboratory and Department of Pathology [L. J., R. V., T. A. P., P. H., A. K., K. A.], and Department of Immunology and Bacteriology and Transplantation Laboratory [R. R., R. A.], Haartman Institute, University of Helsinki, 00014 Helsinki, Finland; Department of Oncology, Helsinki University Central Hospital, 00029 Finland [P. S.]; Centre for Biotechnology, University of Turku, 20520 Turku, Finland [M-T. M.]; Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129 [M. D.]; and Department of Dermatology, University of Vienna, A-1090 Vienna, Austria [E. T.]

Lymphatic vessels have been difficult to study in detail in normal and tumor tissues because of the lack of molecular markers. Here, monoclonal antibodies against the extracellular domain of the vascular endothelial growth factor-C receptor that we have named VEGFR-3 were found to specifically stain endothelial cells of lymphatic vessels and vessels around tumors such as lymphoma and in situ breast carcinoma. Interestingly, the spindle cells of several cutaneous nodular AIDS-associated Kaposi's sarcomas and the endothelium around the nodules were also VEGFR-3 positive. The first specific molecular marker for the lymphatic endothelium should provide a useful tool for the analysis of lymphatic vessels in malignant tumors and their metastases and the cellular origin and differentiation of Kaposi's sarcomas.

1 This work was supported by the Finnish Cancer Research Foundation, The Finnish Academy of Sciences, EU grants BMH4-CT96-0669 and CT98-3380 from the Helsinki University Central Hospital Research Funds, and the Finnish Medical Foundation (to L. J.).

2 To whom requests for reprints should be addressed, at Molecular/Cancer Biology Laboratory and Department of Pathology, Haartman Institute, University of Helsinki, 00014 Helsinki, Finland. Phone: 358-9-1912 6434; Fax: 358-9-1912 6448.

Received 12/29/97. Accepted 3/ 2/98.




This article has been cited by other articles:


Home page
J. Med. Genet.Home page
A Ghalamkarpour, W Holnthoner, P Saharinen, L M Boon, J B Mulliken, K Alitalo, and M Vikkula
Recessive primary congenital lymphoedema caused by a VEGFR3 mutation
J. Med. Genet., June 1, 2009; 46(6): 399 - 404.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. A. Morris, A. S. Punjabi, and M. Lagunoff
Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells
J. Virol., September 1, 2008; 82(17): 8771 - 8779.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Efklidou, R. Bailey, N. Field, M. Noursadeghi, and M. K. Collins
vFLIP from KSHV inhibits anoikis of primary endothelial cells
J. Cell Sci., February 15, 2008; 121(4): 450 - 457.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
A. Y. Debrah, S. Mand, M. R. Toliat, Y. Marfo-Debrekyei, L. Batsa, P. Nurnberg, B. Lawson, O. Adjei, A. Hoerauf, and K. Pfarr
Plasma Vascular Endothelial Growth Factor-A (VEGF-A) and VEGF-A Gene Polymorphism are Associated with Hydrocele Development in Lymphatic Filariasis
Am J Trop Med Hyg, October 1, 2007; 77(4): 601 - 608.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Zhang, J. F. Wang, G. Kunos, and J. E. Groopman
Cannabinoid Modulation of Kaposi's Sarcoma Associated Herpesvirus Infection and Transformation
Cancer Res., August 1, 2007; 67(15): 7230 - 7237.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Wirzenius, T. Tammela, M. Uutela, Y. He, T. Odorisio, G. Zambruno, J. A. Nagy, H. F. Dvorak, S. Yla-Herttuala, M. Shibuya, et al.
Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting
J. Exp. Med., June 11, 2007; 204(6): 1431 - 1440.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. S. Punjabi, P. A. Carroll, L. Chen, and M. Lagunoff
Persistent Activation of STAT3 by Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells
J. Virol., March 1, 2007; 81(5): 2449 - 2458.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Laakkonen, M. Waltari, T. Holopainen, T. Takahashi, B. Pytowski, P. Steiner, D. Hicklin, K. Persaud, J. R. Tonra, L. Witte, et al.
Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
Cancer Res., January 15, 2007; 67(2): 593 - 599.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Grossmann, S. Podgrabinska, M. Skobe, and D. Ganem
Activation of NF-{kappa}B by the Latent vFLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus Is Required for the Spindle Shape of Virus-Infected Endothelial Cells and Contributes to Their Proinflammatory Phenotype
J. Virol., July 15, 2006; 80(14): 7179 - 7185.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. Karpanen, C. A. Heckman, S. Keskitalo, M. Jeltsch, H. Ollila, G. Neufeld, L. Tamagnone, and K. Alitalo
Functional interaction of VEGF-C and VEGF-D with neuropilin receptors
FASEB J, July 1, 2006; 20(9): 1462 - 1472.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Zhang, J. F. Wang, B. Chandran, K. Persaud, B. Pytowski, J. Fingeroth, and J. E. Groopman
Kaposi's Sarcoma-associated Herpesvirus Activation of Vascular Endothelial Growth Factor Receptor 3 Alters Endothelial Function and Enhances Infection
J. Biol. Chem., July 15, 2005; 280(28): 26216 - 26224.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
B. Moller, M. Ronnerdag, G. Wang, V. Odlind, and M. Olovsson
Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system
Hum. Reprod., May 1, 2005; 20(5): 1410 - 1417.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Sugaya, T. Watanabe, A. Yang, M. F. Starost, H. Kobayashi, A. M. Atkins, D. L. Borris, E. A. Hanan, D. Schimel, M. A. Bryant, et al.
Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter
Blood, March 15, 2005; 105(6): 2356 - 2363.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Chen, K. Takenaka, E. Ogawa, K. Yanagihara, Y. Otake, H. Wada, and F. Tanaka
Flt-4-Positive Endothelial Cell Density and Its Clinical Significance in Non-Small Cell Lung Cancer
Clin. Cancer Res., December 15, 2004; 10(24): 8548 - 8553.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. Bono, V.-M. Wasenius, P. Heikkila, J. Lundin, D. G. Jackson, and H. Joensuu
High LYVE-1-Positive Lymphatic Vessel Numbers Are Associated with Poor Outcome in Breast Cancer
Clin. Cancer Res., November 1, 2004; 10(21): 7144 - 7149.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. K. Chang, G. Garcia-Cardena, F. Farnebo, M. Fannon, E. J. Chen, C. Butterfield, M. A. Moses, R. C. Mulligan, J. Folkman, and A. Kaipainen
Dose-dependent response of FGF-2 for lymphangiogenesis
PNAS, August 10, 2004; 101(32): 11658 - 11663.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Zeng, K. Opeskin, M. E. Baldwin, L. G. Horvath, M. G. Achen, S. A. Stacker, R. L. Sutherland, and E. D. Williams
Expression of Vascular Endothelial Growth Factor Receptor-3 by Lymphatic Endothelial Cells Is Associated with Lymph Node Metastasis in Prostate Cancer
Clin. Cancer Res., August 1, 2004; 10(15): 5137 - 5144.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Buttiglieri, M. C. Deregibus, S. Bravo, P. Cassoni, R. Chiarle, B. Bussolati, and G. Camussi
Role of Pax2 in Apoptosis Resistance and Proinvasive Phenotype of Kaposi's Sarcoma Cells
J. Biol. Chem., February 6, 2004; 279(6): 4136 - 4143.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Yao, O. Salvucci, A. R. Cardones, S. T. Hwang, Y. Aoki, M. De La Luz Sierra, A. Sajewicz, S. Pittaluga, R. Yarchoan, and G. Tosato
Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis
Blood, December 1, 2003; 102(12): 3900 - 3905.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. VEIKKOLA, M. LOHELA, K. IKENBERG, T. MAKINEN, T. KORFF, A. SAARISTO, T. PETROVA, M. JELTSCH, H. G. AUGUSTIN, and K. ALITALO
Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function
FASEB J, November 1, 2003; 17(14): 2006 - 2013.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Dixelius, T. Makinen, M. Wirzenius, M. J. Karkkainen, C. Wernstedt, K. Alitalo, and L. Claesson-Welsh
Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation Sites
J. Biol. Chem., October 17, 2003; 278(42): 40973 - 40979.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
R. V. Lalla, D. S. Boisoneau, J. D. Spiro, and D. L. Kreutzer
Expression of Vascular Endothelial Growth Factor Receptors on Tumor Cells in Head and Neck Squamous Cell Carcinoma
Arch Otolaryngol Head Neck Surg, August 1, 2003; 129(8): 882 - 888.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
F. T. Hall, J. L. Freeman, S. L. Asa, D. G. Jackson, and N. J. Beasley
Intratumoral Lymphatics and Lymph Node Metastases in Papillary Thyroid Carcinoma
Arch Otolaryngol Head Neck Surg, July 1, 2003; 129(7): 716 - 719.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
L. A. Dourmishev, A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac
Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis
Microbiol. Mol. Biol. Rev., June 1, 2003; 67(2): 175 - 212.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Yokoyama, D. S. Charnock-Jones, D. Licence, A. Yanaihara, J. M. Hastings, C. M. Holland, M. Emoto, A. Sakamoto, T. Sakamoto, H. Maruyama, et al.
Expression of Vascular Endothelial Growth Factor (VEGF)-D and Its Receptor, VEGF Receptor 3, as a Prognostic Factor in Endometrial Carcinoma
Clin. Cancer Res., April 1, 2003; 9(4): 1361 - 1369.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Krishnan, V. Kirkin, A. Steffen, M. Hegen, D. Weih, S. Tomarev, J. Wilting, and J. P. Sleeman
Differential in Vivo and in Vitro Expression of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in Tumors and Its Relationship to Lymphatic Metastasis in Immunocompetent Rats
Cancer Res., February 1, 2003; 63(3): 713 - 722.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Salven, S. Mustjoki, R. Alitalo, K. Alitalo, and S. Rafii
VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells
Blood, January 1, 2003; 101(1): 168 - 172.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Clarijs, L. Schalkwijk, U. B. Hofmann, D. J. Ruiter, and R. M. W. de Waal
Induction of Vascular Endothelial Growth Factor Receptor-3 Expression on Tumor Microvasculature as a New Progression Marker in Human Cutaneous Melanoma
Cancer Res., December 1, 2002; 62(23): 7059 - 7065.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. A. STACKER, M. E. BALDWIN, and M. G. ACHEN
The role of tumor lymphangiogenesis in metastatic spread
FASEB J, July 1, 2002; 16(9): 922 - 934.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. Jussila and K. Alitalo
Vascular Growth Factors and Lymphangiogenesis
Physiol Rev, July 1, 2002; 82(3): 673 - 700.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
G. Barillari and B. Ensoli
Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma
Clin. Microbiol. Rev., April 1, 2002; 15(2): 310 - 326.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. D. White, P. W. Hewett, D. Kosuge, T. McCulloch, B. C. Enholm, J. Carmichael, and J. C. Murray
Vascular Endothelial Growth Factor-D Expression Is an Independent Prognostic Marker for Survival in Colorectal Carcinoma
Cancer Res., March 1, 2002; 62(6): 1669 - 1675.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
T. MAKINEN and K. ALITALO
Molecular Mechanisms of Lymphangiogenesis
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 189 - 196.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
M. Skobe, L. M. Hamberg, T. Hawighorst, M. Schirner, G. L. Wolf, K. Alitalo, and M. Detmar
Concurrent Induction of Lymphangiogenesis, Angiogenesis, and Macrophage Recruitment by Vascular Endothelial Growth Factor-C in Melanoma
Am. J. Pathol., September 1, 2001; 159(3): 893 - 903.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sakurada, H. Katano, T. Sata, H. Ohkuni, T. Watanabe, and S. Mori
Effective Human Herpesvirus 8 Infection of Human Umbilical Vein Endothelial Cells by Cell-Mediated Transmission
J. Virol., August 15, 2001; 75(16): 7717 - 7722.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Rajantie, N. Ekman, K. Iljin, E. Arighi, Y. Gunji, J. Kaukonen, A. Palotie, M. Dewerchin, P. Carmeliet, and K. Alitalo
Bmx Tyrosine Kinase Has a Redundant Function Downstream of Angiopoietin and Vascular Endothelial Growth Factor Receptors in Arterial Endothelium
Mol. Cell. Biol., July 15, 2001; 21(14): 4647 - 4655.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. J. B. Nibbs, E. Kriehuber, P. D. Ponath, D. Parent, S. Qin, J. D. M. Campbell, A. Henderson, D. Kerjaschki, D. Maurer, G. J. Graham, et al.
The {beta}-Chemokine Receptor D6 Is Expressed by Lymphatic Endothelium and a Subset of Vascular Tumors
Am. J. Pathol., March 1, 2001; 158(3): 867 - 877.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Helske, P. Vuorela, O. Carpen, C. Hornig, H. Weich, and E. Halmesmaki
Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies
Mol. Hum. Reprod., February 1, 2001; 7(2): 205 - 210.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. O. Hiltunen, M. Laitinen, M. P. Turunen, M. Jeltsch, J. Hartikainen, T. T. Rissanen, J. Laukkanen, M. Niemi, M. Kossila, T. P. Hakkinen, et al.
Intravascular Adenovirus-Mediated VEGF-C Gene Transfer Reduces Neointima Formation in Balloon-Denuded Rabbit Aorta
Circulation, October 31, 2000; 102(18): 2262 - 2268.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. A. PARTANEN, J. AROLA, A. SAARISTO, L. JUSSILA, A. ORA, M. MIETTINEN, S. A. STACKER, M. G. ACHEN, and K. ALITALO
VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues
FASEB J, October 1, 2000; 14(13): 2087 - 2096.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. J. Leu, D. A. Berk, A. Lymboussaki, K. Alitalo, and R. K. Jain
Absence of Functional Lymphatics within a Murine Sarcoma: A Molecular and Functional Evaluation
Cancer Res., August 1, 2000; 60(16): 4324 - 4327.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
A. Saaristo, T. A. Partanen, J. Arola, L. Jussila, M. Hytonen, A. Makitie, S. Vento, A. Kaipainen, H. Malmberg, and K. Alitalo
Vascular Endothelial Growth Factor-C and Its Receptor VEGFR-3 in the Nasal Mucosa and in Nasopharyngeal Tumors
Am. J. Pathol., July 1, 2000; 157(1): 7 - 14.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
S. D. Nathanson, R. J. Zarbo, D. L. Wachna, C. A. Spence, T. A. Andrzejewski, and J. Abrams
Microvessels That Predict Axillary Lymph Node Metastases in Patients With Breast Cancer
Arch Surg, May 1, 2000; 135(5): 586 - 594.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Paavonen, P. Puolakkainen, L. Jussila, T. Jahkola, and K. Alitalo
Vascular Endothelial Growth Factor Receptor-3 in Lymphangiogenesis in Wound Healing
Am. J. Pathol., May 1, 2000; 156(5): 1499 - 1504.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Veikkola, M. Karkkainen, L. Claesson-Welsh, and K. Alitalo
Regulation of Angiogenesis via Vascular Endothelial Growth Factor Receptors
Cancer Res., January 1, 2000; 60(2): 203 - 212.
[Full Text]


Home page
J. Biol. Chem.Home page
S. Marchio, L. Primo, M. Pagano, G. Palestro, A. Albini, T. Veikkola, I. Cascone, K. Alitalo, and F. Bussolino
Vascular Endothelial Growth Factor-C Stimulates the Migration and Proliferation of Kaposi's Sarcoma Cells
J. Biol. Chem., September 24, 1999; 274(39): 27617 - 27622.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. A. Partanen, T. Makinen, J. Arola, T. Suda, H. A. Weich, and K. Alitalo
Endothelial Growth Factor Receptors in Human Fetal Heart
Circulation, August 10, 1999; 100(6): 583 - 586.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. V. Moses, K. N. Fish, R. Ruhl, P. P. Smith, J. G. Strussenberg, L. Zhu, B. Chandran, and J. A. Nelson
Long-Term Infection and Transformation of Dermal Microvascular Endothelial Cells by Human Herpesvirus 8
J. Virol., August 1, 1999; 73(8): 6892 - 6902.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
G. Siemeister, M. Schirner, K. Weindel, P. Reusch, A. Menrad, D. Marme, and G. Martiny-Baron
Two Independent Mechanisms Essential for Tumor Angiogenesis: Inhibition of Human Melanoma Xenograft Growth by Interfering with either the Vascular Endothelial Growth Factor Receptor Pathway or the Tie-2 Pathway
Cancer Res., July 1, 1999; 59(13): 3185 - 3191.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Valtola, P. Salven, P. Heikkila, J. Taipale, H. Joensuu, M. Rehn, T. Pihlajaniemi, H. Weich, R. deWaal, and K. Alitalo
VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
Am. J. Pathol., May 1, 1999; 154(5): 1381 - 1390.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Dupin, C. Fisher, P. Kellam, S. Ariad, M. Tulliez, N. Franck, E. van Marck, D. Salmon, I. Gorin, J.-P. Escande, et al.
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma
PNAS, April 13, 1999; 96(8): 4546 - 4551.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Breiteneder-Geleff, A. Soleiman, H. Kowalski, R. Horvat, G. Amann, E. Kriehuber, K. Diem, W. Weninger, E. Tschachler, K. Alitalo, et al.
Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic Capillaries : Podoplanin as a Specific Marker for Lymphatic Endothelium
Am. J. Pathol., February 1, 1999; 154(2): 385 - 394.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak
Vascular endothelial growth factor (VEGF) and its receptors
FASEB J, January 1, 1999; 13(1): 9 - 22.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
A. Lymboussaki, T. A. Partanen, B. Olofsson, J. Thomas-Crusells, C. D. M. Fletcher, R. M. W. de Waal, A. Kaipainen, and K. Alitalo
Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular Tumors
Am. J. Pathol., August 1, 1998; 153(2): 395 - 403.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.